![](/img/cover-not-exists.png)
Comparison of Treatment Outcomes between Analysis Populations in the RESTORE-IMI 1 Phase 3 Trial of Imipenem-Cilastatin-Relebactam versus Colistin plus Imipenem-Cilastatin in Patients with Imipenem-Nonsusceptible Bacterial Infections
Kaye, Keith S., Boucher, Helen W., Brown, Michelle L., Aggrey, Angela, Khan, Ireen, Joeng, Hee-Koung, Tipping, Robert W., Du, Jiejun, Young, Katherine, Butterton, Joan R., Paschke, AmandaVolume:
64
Journal:
Antimicrobial Agents and Chemotherapy
DOI:
10.1128/AAC.02203-19
Date:
February, 2020
File:
PDF, 281 KB
2020